Device Industry Grab-Bag Of Provisions In 21st Century Cures Draft
This article was originally published in The Gray Sheet
Executive Summary
Device industry advocates have a lot of reading to do. There are more than two dozen provisions with relevance to the medtech sector, many aimed at smoothing the way for product approvals and reimbursement, in a 21st Century Cures discussion draft unveiled by the House Energy and Commerce panel Jan. 27. The initial proposal does not have bipartisan support.